Ryufin

Reckitt Benckiser Group plc

United Kingdom · GB00BSZBP530 · reports in GBP · Europe

The answers

From the annual report for the year to Dec 31, 2025. Each line says what it is based on.

Is it growing?Fair
Revenue +0.3% in the year to Dec 31, 2025, on the year before.
Is it a good business?Good
It earned 41% on its shareholders' equity in the year to Dec 31, 2025.
Is it safe?Fair
Equity is 31% of its assets, and operations brought in cash in the year.
Is the price fair?n/a
Not answered: no exchange publishes this company's price for free reuse, so there is no P/E here.

The year

Year to Dec 31, 2025, consolidated, in GBP.

£14.2B

revenue

30%

operating margin

£3.2B

net profit

Year by year

As filed; an earlier year can differ from its own report when the company restated it.

Dec 2022Dec 2023Dec 2024Dec 2025
Revenue£14.5B£14.6B£14.2B£14.2B
Operating profit£3.2B£2.5B£2.4B£4.2B
Net profit to shareholders£2.3B£1.6B£1.4B£3.2B
Earnings per share£3.26£2.29£2.04£4.68
Cash from operations£2.4B£2.6B£2.7B£2.3B
Capital spending£362M£348M£370M£536M
Cash£1.2B£1.4B£880M£2.0B
Total assets£28.7B£27.1B£25.3B£25.1B
Equity£9.5B£8.5B£6.7B£7.8B

What they do

In the company's own words, from the annual report.

Our purpose is to protect, heal and nurture in pursuit of a cleaner, healthier world 2025 was a year of delivery as we sharpened our strategic focus and strengthened our foundations for sustainable growth. We have simplified the Business and aligned behind the Powerbrands that now represent the majority of our net revenue. Across markets and categories, we are executing with excellence, driving efficiency, improving performance and investing in the innovations of the future, delivering consistently, building momentum and generating value for our shareholders.

Source: the company’s annual financial report in ESEF, via filings.xbrl.org (XBRL International). Listed shares from ESMA’s FIRDS register; ESMA does not endorse this site. Ryufin computed the answers and ratios from the filed figures.